United States Diabetes Market to Reach US$ 38.8 Billion by 2032, Development of Continuous Glucose Monitoring (CGM) Devices Propelling Growth

August 16, 2019 | Healthcare

As per the latest report by IMARC Group, titled “United States Diabetes Market Report: 2024-2032”, the United States diabetes market size reached US$ 29.3 Billion in 2023. Diabetes, also known as diabetes mellitus, is a chronic disease in which the ability of the human body to produce or respond to the hormone insulin becomes impaired. It results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. It can also cause severe health complications such as low vision, kidney failure, heart disease and lower-extremity amputations. As per the report released by the Centers for Disease Control and Prevention (CDC) in 2017, more than 100 million adults in the United States are living with diabetes or prediabetes.

United States Diabetes Market Trends:

On account of the rising prevalence of diabetes, the US Government has launched various prevention programs for raising awareness about its symptoms and encouraging a healthier lifestyle amongst individuals. For instance, the CDC started the National Diabetes Prevention Program (National DPP) to prevent type 2 diabetes in the country. The main objective of the program is to encourage patients to increase physical activity and improve their eating habits. In line with this, there has been a rise in the diabetes diagnosis, monitoring and treatment rates in the country. Further, technological advancements have enabled manufacturers to develop continuous glucose monitoring (CGM) devices that allow type-2 diabetes patients to check their blood periodically using testing strips. Apart from this, the US Food and Drug Administration (FDA) has recently approved the production of Basaglar and Admelog, the biosimilars of insulin glargine and lispro. Several other diabetes drugs are also projected to gain approval in the coming years, which will further drive the growth of the market. Owing to these factors, the market value is expected to reach US$ 38.8 Billion by 2032, expanding at a CAGR of 3.1% during 2024-2032.

Market Summary:

Breakup by Segment:

The market has been bifurcated into the oral antidiabetics and insulin segments. At present, insulin accounts for the majority of the total market share. This can be attributed to the enhanced convenience and efficacy offered by insulin delivery systems. Insulin is usually taken through pen, syringe, pumps and jet injectors, with the insulin pen being preferred the most in the country.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being Sanofi US Services Inc., Novo Nordisk Inc., Eli Lilly and Company, Merck & Co., Inc., Zeneca Holdings Inc. and Johnson & Johnson.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
United States Diabetes Market to Reach US$ 38.8 Billion by 2032, Development of Continuous Glucose Monitoring (CGM) Devices Propelling Growth
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More